CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 2.63: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
34.88BINR364.36M · vs all stocks (USD)
Revenue (TTM)
14.31BINR149.53M · vs all stocks (USD)
Profit Margin
-0.11%Beta
0.9230xvs all stocks
52-Week Change
12.40%vs all stocks
Market Capitalization
34.88BINR364.36M · vs all stocks (USD)
Enterprise Value
40.74BINR425.59M · vs all stocks (USD)
Forward P/E
23.99xPrice to Sales (TTM)
2.54xPrice to Book (MRQ)
2.62xEnterprise to Revenue
2.85xEnterprise to EBITDA
21.46xGross Margin
48.52%Profit Margin
-0.11%Operating Margin
9.24%Return on Assets (TTM)
-0.32%Return on Equity (TTM)
-0.59%Revenue (TTM)
14.31BINR149.53M · vs all stocks (USD)
Revenue per Share (TTM)
318.10INRUpdated Sep 23, 2026Quarterly Revenue Growth
19.60%Gross Profit (TTM)
6.97BINR72.80M · vs all stocks (USD)
EBITDA (TTM)
2.00BINR20.85M · vs all stocks (USD)
Net Income (TTM)
-16.20MINR-169.23K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
55.00%Operating Cash Flow (TTM)
1.53BINR15.97M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-74.10MINR-774.05K · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
26.70MINRFY2026 · Mar 31, 2026Revenue
13.69BINRFY2026 · Mar 31, 2026Cost of Goods Sold
6.85BINRFY2026 · Mar 31, 2026Gross Profit
6.84BINRFY2026 · Mar 31, 2026Operating Income
870.70MINR9.10M · vs all stocks (USD)
Pre-tax Income
-74.10MINRFY2026 · Mar 31, 2026Income Tax Expense
0.00INRFY2026 · Mar 31, 2026Net Income
-74.10MINRFY2026 · Mar 31, 2026EBIT
873.40MINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
1.93BINRFY2026 · Mar 31, 2026Other Operating Expenses
2.79BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
947.50MINRFY2026 · Mar 31, 2026EPS (Basic)
-1.68INRFY2026 · Mar 31, 2026EPS (Diluted)
-1.68INRFY2026 · Mar 31, 2026Basic Shares Outstanding
44.11MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
44.11MSharesFY2026 · Mar 31, 2026Net Income from Continuing Operations
-74.10MINRFY2026 · Mar 31, 2026Minority Interests (P&L)
0.00INRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
250.10MINRFY2026 · Mar 31, 2026Free Cash Flow
245.00MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
44.80MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
-74.10MINRFY2026 · Mar 31, 2026Stock-based Compensation
46.70MINRFY2026 · Mar 31, 2026Other Non-cash Items
918.20MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.11BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
472.50MINRFY2026 · Mar 31, 2026Capital Expenditures
5.10MINRFY2026 · Mar 31, 2026Net Acquisitions
800.00KINRFY2026 · Mar 31, 2026Purchase of Investments
-487.00MINRFY2026 · Mar 31, 2026Other Investing Activity
10.70MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-470.40MINRFY2026 · Mar 31, 2026Long-term Debt Issuance
495.00MINRFY2026 · Mar 31, 2026Long-term Debt Payments
-888.90MINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-768.10MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
423.20MINRFY2026 · Mar 31, 2026Shares Outstanding
48.08MSharesUpdated Sep 23, 2026Float Shares
31.92MSharesUpdated Sep 23, 2026% Held by Insiders
52.24%vs all stocks
% Held by Institutions
16.66%vs all stocks
Total Cash (MRQ)
533.40MINR5.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
11.51INRUpdated Sep 23, 2026Total Debt (MRQ)
6.87BINR71.72M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5468xCurrent Ratio (MRQ)
0.9599xBook Value per Share (MRQ)
287.12INRUpdated Sep 23, 2026Total Assets
23.33BINR243.66M · vs all stocks (USD)
Total Current Assets
8.58BINRFY2026 · Mar 31, 2026Total Liabilities
10.77BINRFY2026 · Mar 31, 2026Total Non-current Assets
14.74BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
1.83BINRFY2026 · Mar 31, 2026Total Current Liabilities
8.94BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
44.80MINRFY2026 · Mar 31, 2026Other Short-term Investments
554.00MINRFY2026 · Mar 31, 2026Accounts Receivable
4.39BINRFY2026 · Mar 31, 2026Inventory
3.18BINRFY2026 · Mar 31, 2026Accounts Payable
2.74BINRFY2026 · Mar 31, 2026Short-term Debt
5.57BINRFY2026 · Mar 31, 2026Other Current Liabilities
163.60MINRFY2026 · Mar 31, 2026Long-term Debt
1.30BINRFY2026 · Mar 31, 2026Common Stock (Book)
445.10MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
12.56BINR131.15M · vs all stocks (USD)
52-Week Low
422.00INRUpdated Sep 23, 202652-Week High
774.00INRUpdated Sep 23, 202652-Week Change
12.40%vs all stocks
Beta
0.9230xvs all stocks
50-Day MA
591.99INRUpdated Sep 23, 2026200-Day MA
536.84INRUpdated Sep 23, 2026Avg 10-Day Volume
642.26KSharesUpdated Sep 23, 2026Avg 30-Day Volume
716.08KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
-0.5900INRUpdated Sep 23, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.49Profit Margin: -0.00
Financial Health
Altman Z-Score 2.63: safe zoneNotable
Altman Z-Score: 2.63
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shin Poong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Qinghai Spring Medicinal Resources Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
C4 Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Sito Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Cowin Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orchestra BioMed Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Fennec Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Aska Pharmaceutical Holdings Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
NIOX Group plc
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Huasun Technology Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule